WHO Approves Two New Drug to Treat COVID-19

Daily Current Affairs / WHO Approves Two New Drug to Treat COVID-19

Change Language English Hindi

Category : International Published on: January 17 2022

Share on facebook

The World Health Organization has approved two new drugs for two new COVID-19 treatments that will help expand its arsenal of vaccines as well as tools to prevent serious illness and virus deaths.
These two drug are baricitinib and casirivimab-imdevimab.
The WHO has recommended Eli Lilly & Co.’s rheumatoid arthritis drug and GlaxoSmithKline Plc’s monoclonal antibody.
Lilly's baricitinib drug is a Janus kinase (JAK) inhibitor- a class of drugs used to treat autoimmune conditions, blood and bone marrow cancers, and rheumatoid arthritis.

Weekly Current Affairs (21st April to 27th April 2024)
Read More....
Weekly Current Affairs (21st April to 27th April 2024)
Read More....
Weekly Current Affairs (21st April to 27th April 2024)
Read More....
Weekly Current Affairs (21st April to 27th April 2024)
Read More....
Weekly Current Affairs (21st April to 27th April 2024)
Read More....
Weekly Current Affairs (21st April to 27th April 2024)
Read More....
Weekly Current Affairs (21st April to 27th April 2024)
Read More....
Weekly Current Affairs (21st April to 27th April 2024)
Read More....
Weekly Current Affairs (21st April to 27th April 2024)
Read More....
Weekly Current Affairs (21st April to 27th April 2024)
Read More....
Weekly Current Affairs (21st April to 27th April 2024)
Read More....
Weekly Current Affairs (21st April to 27th April 2024)
Read More....

WHO Approves Two New Drug to Treat COVID-19